Column Group III LP Buys 15,100 Surrozen Shares, Signals Confidence in Biotech Pipeline【SZO】
Column Group III GP’s latest $19.89 buy of 15,100 Surrozen shares shows long‑term confidence in its biotech pipeline, hinting at upside if clinical milestones hit.
3 minutes to read